Keywords
Immediate implant, extraction socket, jumping gap distance, A-PRF, DFDBA
This article is included in the Datta Meghe Institute of Higher Education and Research collection.
Immediate implant, extraction socket, jumping gap distance, A-PRF, DFDBA
Dental implant therapy has advanced over time, resulting in predictable, effective, and successful treatment outcomes. During an immediate implant placement procedure, an implant will be placed straight away into an extraction socket after the tooth extraction.1 It reduces the duration of treatment and improves patient comfort. The dimensions of the sockets after extraction are often much larger than the diameters of the implants. While gap can occur at any surface of immediate implant, the buccal bone is of particular importance as it is usually thin and has tendency for resorption and soft tissue recession. The horizontal distance (HD)/jumping gap distance (JGD) is the distance between implant and surrounding alveolus.2 The surface of implants exhibits spontaneous osseointegration and bone healing when possessing HD of ≤1.5 mm. HD of >1.5 mm affects spontaneous bone healing. In order to resolve this issue, combining various materials like bone grafts with growth factor (GF) rich platelet concentrates has the added benefit of promoting faster and more effective healing.
When used to treat intraosseous periodontal defects, DFDBA has shown considerable improvements in clinical tissue parameters in both soft and hard tissues.3 Bone morphogenic proteins found in the DFDBA encourage local cell division to produce new bone.4
The fibrin meshwork structure of A-PRF that results from the polymerisation of the platelets and leukocyte concentration is the factor that influences the release of GF for up to a period of 10 days during the reorganisation of the wound.5,6 PRF production protocol at reduced centrifugation speed (1500 rpm for 14 minutes) produces A-PRF. A-PRF favours the release of higher amount of GFs than PRF, which might affect tissue regeneration directly. There hasn't been research yet to evaluate combined effect of A-PRF and DFDBA placement in peri-implant void on hard and soft tissue alterations followed by immediate implant placement. Therefore, an intent of this study is to evaluate the efficiency of combination of A-PRF in with DFDBA placed simultaneously into an extraction socket followed by placement of immediate implant on the clinical and radiological outcomes.
To evaluate efficacy of A-PRF and DFDBA in implants placed in fresh extraction socket on the clinical and radiological outcomes.
1. To evaluate the horizontal and vertical crestal bone changes around immediate implants sockets augmented with A-PRF and DFDBA.
2. To evaluate the changes in the buccolingual dimension of socket around immediate implants augmented with A-PRF and DFDBA.
3. To evaluate the success rate of an immediate implant placed simultaneously with a combination of A-PRF and DFDBA placement.
The study proposal is approved by “Institutional Ethics Committee” with Ref. No. DMIHER (DU)/IEC/2023/577 on 06/02/2023.
Name of registry - Clinical Trial Registry of India
REF No. ‐ REF/2023/03/064371
URL - https://ctri.nic.in/Clinicaltrials/main1.php?EncHid=97508.22015
Submitted to CTRI on ‐ 04/03/23
Sample size calculation
Primary Variable (Buccolingual dimention of socket wall)
(Immediate implant placement, difference after 6 months) Mean ± SD. = 0.10 ± 0.09
As per reference articles - Bhombe et al (2022)
Total samples required =13 per Group.
The calculation gives the result as 13, thus a round figure of 12 samples will be used for the study. This will be a single arm prospective clinical study.
Study population
In this study, 12 implants will be placed in systemically healthy individuals who have a need for tooth/teeth replacement through implant from the outpatient “Department of Periodontics”.
Inclusion criteria
1. Teeth that require extraction due to fracture of root, residual roots, internal and external resorption, endodontic failures, non-restorable carious lesions, over-retained deciduous teeth.
2. Good oral hygiene, with a full mouth plaque score of less than 25%.
3. Thick gingival biotype.
4. Intact alveolar bony walls appeared both clinically and radiographically.
5. At least 4mm bone must be present below root apex.
6. Bone quality: D1 and D2.
7. The HD should be more than 1.5 mm.
Exclusion criteria
1. Altered health conditions that would interfere with bone healing e.g. diabetic patients, blood disorders, osteoporosis, and people allergic to titanium, etc.
2. Space discrepancies between maxilla-mandible.
3. Bone quality: D3 and D4.
4. Implant site having <2mm of width of keratinized gingiva.
5. Para functional habits.
6. Proclined teeth, mal-aligned or rotated anterior teeth, teeth with interdental spacing.
7. Untreated dental diseases.
8. Debilitating tempromandibular (TMJ) joint pathosis.
9. Habit of smoking, alcohol intake or drug abuse.
10. Pregnant woman, lactating mother.
Only type I extraction sites will be chosen based on the preoperative classification given by Salama and Salama in 1993.7 Before the study begins, details about nutritional status, oral hygiene practises, detailed medical history, and periodontal health status will be recorded in a specially designed case history. Patients will be evaluated under good illumination using William’s graduated probe and mouth mirror. They will be informed about the design and purpose of the clinical trial before the study begins, and their written consent will be obtained.
This study will be conducted over the course of a year. Twelve implants will be placed in individuals with need of extraction of maxillary and/or mandibular teeth. They will be recruited from the outpatient department of “Department of Periodontics and Implantology, Sharad Pawar Dental College, Sawangi, (Meghe)”. Using a two-stage protocol, implant placement will be done into the fresh extraction socket after the socket has been augmented with A-PRF and DFDBA. Three months after the placement of an implant, a second stage surgery will be performed. Following second stage surgery, abutments will be connected and a prosthesis will be placed within 2 to 4 weeks. Before the procedure, 3 months after implant placement, and 6 months following permanent prosthesis the clinical parameters will be evaluated, which include probing depths around implants, the full mouth modified plaque index (FMPI), the modified papillary bleeding index (FMPBI), and implant mobility using the clinical implant mobility scale (CIMS). Cone Beam Computed Tomography (CBCT) will be obtained for preoperative assessment.8
Primary outcomes
Primary outcome will be the vertical and horizontal crestal bone changes around immediately placed implants.
Secondary outcomes
Secondary outcome will the implant mobiliy.
Clinical indices
Clinical indices will be obtained at three different times: baseline, three months after an implant has been placed, and six months after the final prosthesis. The operator will record the clinical indices for each patient. A mean calculation of these will be obtained for the purpose of assessing the results. The FMPI given by “Turesky – Gilmore – Glickman Modification of Quigley Hein” (1970) will be used to determine oral hygiene status.9 The FMPBI given by “Muhlemann HR.” (1977) will be used to evaluate gingival inflammation.10
a. Width of keratinized gingiva (WKG): Using a University of North Carolina (UNC 15) probe, the WKG on the buccal aspect will be determined which is the distance between the gingival margin and muco-gingival junction.
b. Gingival biotype: A thin or thick gingival biotype will be determined (Muller et al., 2000).11
CBCT will be used for preoperative diagnosis and evaluation of available bone (volumetric) to guide implant placement. The information from these scans can be used to precisely analyse the paranasal sinuses, craniofacial bones, and also the degree of sinus pneumetization.12
Following a comprehensive examination and diagnosis, a full mouth scaling will be done, followed by oral hygiene instructions. Until an individual achieves a plaque score of less than 1, the plaque control instructions will be repeated. To determine the maxillo-mandibular relationship, diagnostic casts of each individual will be made prior to the surgical phase. CBCT will be obtained for everyone, and clinical photos will be taken periodically throughout the process.
Extraction of tooth
Following complete asepsis and the administration of local anaesthesia, sulcular incisions will be made on the buccal and lingual/palatal surfaces of the tooth to be extracted. In order to visualise the bone plates, full thickness mucoperiosteal flaps reflection will be done on the buccal and palatal/lingual aspects.
Atraumatic extraction will be performed to minimise trauma to the alveolus and achieve minimal socket expansion. An initial incision will be made with a Bard Parker surgical blade of no. 12 or 15, followed by the separation of the supracrestal gingival fibres and periodontal ligament on the mesial and distal aspects of the root. The tooth will then be extracted mainly using periotome, or if there is sufficient tooth structure, the tooth may be carefully extracted with extraction forceps.
After the extraction of a tooth, the sockets will be inspected for fractures in the socket walls and then thoroughly debrided. If required, ridge alveoloplasty will be performed to achieve a flat bone surface of sufficient width. The sockets will be curated to induce fresh bleeding. Normal saline will be used to irrigate the extraction sockets, which will then be packed for 5 minutes with gauze soaked in normal saline. To measure the root length of an extracted tooth, UNC 15 probe will be used, while the mesiodistal and buccolingual dimensions of the tooth will be measured with a Vernier Caliper, and these values will be correlated with radiographic findings to determine the diameter and length of an implant.
Placement of an implant
After osteotomy site preparation, implants of appropriate length and diameter will be placed in the recipient site. Implant shoulder would be located at or not more than 1 mm apical to the crestal bone, equating to around 3mm apical to the free gingival margin. The JGD will be measured after the implant placement, and only implants with a gap of 1.5 mm or more will be considered for the study. A-PRF will be prepared by drawing 5 ml of blood from the patient, transferring it to sterile, plain glass-based tubes within 30 seconds, and placing them in a centrifuge machine. Using single-spin centrifugation, it will be centrifuged for 14 minutes at 1500 rpm. Following centrifugation, A-PRF clot will be obtained. DFDBA particles with A-PRF will be placed in the extraction site and will be intimately packed.
At the time of insertion, the primary stability will be checked by recording the insertion torque value. After stabilisation, the buccal flap will be placed around the implant, and simple interrupted suturing will be done to suture it to the lingual/palatal flap. Immediate postoperative radiographs will be taken as a baseline record and to confirm complete seating of the implants.
Second stage surgery
Three months after implant placement, the second stage surgery will be performed. The implants will be uncovered by removing the cover screw and replacing it with a gingival former, allowing guided soft tissue healing around 9-10 days. Patients will be given medication after surgery and continue it for at least 3 days post-surgery.
Prosthetic reconstruction
Abutment connection followed by definitive prosthesis will be carried out 9-10 days after removal of gingival former.
Six months after the placement of a definitive prosthesis, a complete re-evaluation will be conducted. Clinical parameters will be evaluated, which include probing measurements around implants, FMPBI, FMPI, and implant mobility with the help of CIMS.13,14 Radiographic parameters will be assessed using CBCT. Any biological & technical complications will also be examined.
The mean and standard deviation (Mean ± SD) values of all the clinical parameters, including FMPI, FMPBI, PPD, buccolingual socket dimension, and radiographic marginal bone level, will be computed. Mean data from the first, third, and sixth months of all patients' treatment will be compared to determine statistical significance. All patients' baseline values will be compared to those at 3 months, and to 6 months after final prosthesis, using Student's paired test. If the probability value (p) is greater than >0.05, the observed difference will be considered statistically insignificant; otherwise, it will be considered significant.
A clinical study assessed the efficacy of “hydroxyapatite” (HA) coated and “titanium plasma-sprayed” implants placed in fresh extraction sockets with respect to its effect on new bone formation and bone-implant contact.15 The investigators came to the conclusion that bone regeneration was significantly more effective when “DFDBA” and a “GTR” barrier material were used together than when a barrier membrane was used alone.
In another study, investigators compared immediate implant placement with “DFDBA” to that with “modified HA”.16 Here, both groups produced outcomes that were equivalent. Around implants, the mean bone level remained steady and even improved.
Presence of periapical infections may present obstacles for immediate implant placement. However, a study assessed an effectiveness of “platelet concentrates” when combine with an “allograft” (DFDBA)17 on implants placed in extraction sockets with periapical infections. The biomaterials used were meant to fill the JGD. The frequency of outcome measures was assessed at baseline, 3 months, 6 months, and 12 months, which included FMPI, FMBI and gingival aesthetic score. Radiographic parameters were assessed on CBCT at the start of the study and 12 months following implant loading. There were statistically significant differences seen in all periodontal parameter however the gingival aesthetic score greatly improved on the interproximal and midfacial regions. This study also reported an increased implant survival rate in one year.
The various platelet concentrates when combined with allografts are known for their use in managing JGD. Bhombe et al. assessed the combined effect of “PRF matrix” with “DFDBA” in JGD fill.18 Implant loading was performed three months after implant placement, following two stage protocol. Clinical and radiographic parameters were evaluated at baseline, 3 months, and 6 months. Six months after loading, the implant success was 100%. The authors reported that buccolingual dimensions were preserved, and bone resorption was significantly reduced.
Thus, the purpose of this study is to assess the combined efficacy of A-PRF and DFDBA placed in a fresh extraction socket following immediate implant placement using a two-stage approach. This study plan will be reliable to prove advantages pertaining to improvements in the following parameters, such as fewer surgical procedures required, preservation of sufficient bone height, and improved aesthetic results.
The bone fill and bone defect resolution achieved by the augmentation procedures have been proven to be successful. Reduced horizontal bone resorption may be achieved by simultaneous implant placement with bone augmentation. After using A-PRF and DFDBA, we anticipate faster and more effective healing, which will benefit osseointegration and implant stability. The improvement in bone volume, bone height, and bone density will be confirmed by clinical and radiological parameters.
Zenodo: SPIRIT checklist for ‘Evaluation of effectiveness of advanced platelet rich fibrin (A-PRF) with demineralized freeze-dried bone allograft (DFDBA) placed into fresh extraction sockets with immediate implant placement: A clinical and radiographic study’, https://doi.org/10.5281/zenodo.7780095.
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the rationale for, and objectives of, the study clearly described?
Partly
Is the study design appropriate for the research question?
Partly
Are sufficient details of the methods provided to allow replication by others?
Partly
Are the datasets clearly presented in a useable and accessible format?
Not applicable
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: tissue engineering, oral and maxillofacial surgery
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
No
Are sufficient details of the methods provided to allow replication by others?
No
Are the datasets clearly presented in a useable and accessible format?
Partly
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Periodontics, Biomaterials, Dental implants.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 1 25 Apr 23 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)